- US11707522utility2023Human Antibodies to Tn Antigen0 cites
- US11701478utility2023Method for Coating Microstructured Components0 cites
- US11702628utility2023Perfusion Medium for Culturing Mammalian Cells and Reducing Cell Bleed in a Perfusion Cell Culture0 cites
- US11690848utility2023Alkoxy Pyrazoles as Soluble Guanylate Cyclase Activators0 cites
- US11691960utility20232-[thiophen-2-yl)formamido]-n-(phenyl)-2-methylpropanamide Derivatives and the Use Thereof as Medicament0 cites
- US11691977utility2023Cyclic Ether Derivatives of Pyrazolo[1,5-a]pyrimidine-3-carboxyamide0 cites
- US11666590utility2023Pharmaceutical Composition, Methods for Treating and Uses Thereof0 cites
- US11661430utility2023Tetrazole Derivatives as TRPA1 Inhibitors0 cites
- US11661427utility2023Tetrazole Derivatives as TRPA1 Inhibitors0 cites
- US11661458utility2023Anti-nrp1a Antibodies and Their Uses for Treating Eye or Ocular Diseases0 cites
- US11642476utility2023Nebulizer0 cites
- US11608343utility2023Substituted Pyrimido[5,4-d]pyrimidines as HER2 Inhibitors0 cites
- USRE049446reissue2023Oxadiazolopyridine Derivatives for Use as Ghrelin O-acyl Transferase (GOAT) Inhibitors0 cites
- US11597903utility2023Cell-controlled Perfusion in Continuous Culture0 cites
- US11583532utility2023Triazolopyrimidine Derivatives for Use as Ghrelin O-acyl Transferase (GOAT) Inhibitors0 cites
- US11578080utility2023Thienopyrimidones0 cites
- US11578129utility2023LRP5 and PD-1 Antagonist Anticancer Combination Therapy0 cites
- US11572385utility2023Process for the Preparation of Concentrated Liquid Formulations Containing Biomolecules0 cites
- US11564886utility2023Pharmaceutical Compositions0 cites